Abstract
Backgrounds and Aims: ESD is a standard endoscopic therapy of early gastric cancer (EGC) and Early esophageal cancer (EEC) which ha invaded to the mucosal or submucosal layer. ESD can be nowadays performed with more expanded indications compared to conventional endoscopic mucosal resection. We evaluate the complication rate and safety of ESD. Materials and Methods: We retrospectively reviewed 511 cases of EGC, EEC, gastric adenoma, and gastric submucosal tumors treated with ESD at Digestive Disease Center, Soon Chun Hyang University Hospital from February, 2003 to November, 2006.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
